Tamsulosin Hydrochloride
Product Images NDC 42254-012
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Tamsulosin Hydrochloride (NDC 42254-012). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure1 (1ceb560b 1a62 408d 8e30 23113e8c9dd3 02)
Figure 2a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 03)
This appears to be a table showing the mean change in a certain variable for different treatments and durations of treatment. The variable is not clear from the available text. The treatments listed are L, A, and placebo, with varying dosages indicated in milligrams. The duration of treatment ranges from 7 to 13 weeks. Without further information, it is not possible to provide more detail about the context or purpose of this table.*
Figure 2b (1ceb560b 1a62 408d 8e30 23113e8c9dd3 04)
Figure3a (1ceb560b 1a62 408d 8e30 23113e8c9dd3 05)
This seems to be a table related to a medical study, evaluating the effects of a specific treatment compared to the placebo. The study measured a parameter referred to as "mL/sec" and lasted for 13 weeks, with data reported for each week. There were a variable number of participants at each timepoint, ranging from 617 to 755. No information is given regarding the nature of the treatment, the condition being treated, or the results of the study.*
Figure3b (1ceb560b 1a62 408d 8e30 23113e8c9dd3 06)
Tamsulosin HCl 0.4mg (1ceb560b 1a62 408d 8e30 23113e8c9dd3 07)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.